• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION ENTERRA; INTESTINAL STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION ENTERRA; INTESTINAL STIMULATOR Back to Search Results
Model Number NEU_ENTERRA_INS
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Diarrhea (1811); Purulent Discharge (1812); Erythema (1840); Unspecified Infection (1930); Nausea (1970); Vomiting (2144); Bowel Perforation (2668); Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/02/2020
Event Type  Injury  
Manufacturer Narrative
Continuation of concomitant medical product(s): product id neu_enterra_ins, product type implantable neurostimulator; product id neu_enterra_ins, product type implantable neurostimulator; product id neu_unknown_lead, product type lead.Device information references the main component of the system.Other relevant device(s) are: product id: neu_enterra_ins, unknown product id: neu_enterra_ins, product id: neu_unknown_lead.Please note that event date is based off of the date of publication of the article [or the date that the article was accepted for publication] as the event dates were not provided in the published literature.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Condon, a., patel, a., shah, n., et al.(2020).Gastric electrical stimulators causing erosion through the colonic wall.Acg case reports journal.2020;7:e00313.Doi:10.14309/crj.0000000000000313 summary: gastroparesis is a chronic motor disorder of the stomach characterized by the demonstration of delayed gastric emptying without obstruction and a grouping of symptoms including nausea, vomiting, early satiety, postprandial fullness, bloating and abdominal pain.When conservative medical management is not effective,gastric electrical stimulation is an effective alternative.Gastric electrical stimulation, in general, has had a low complication rate as of yet, with the most common being infection of the implanted device.We present a complication in which the gastric electrical stimulator electrodes eroded through the colonic wall.Reported event: 1.       male patient, aged 59 years old had a placement of the gastric electrical stimulator in july 2010.Patient has required up to 4 revisions.Patient¿s multiple hardware infections with device exchanges have complicated thir course, including the most recent infection in 2017, resulting in the total replacement of the gastric electrical stimulator and placement of tobramycin stimulan beads.Patient¿s most recent revision was in august 2018, just 1 month before presenting for a battery replacement.Most recently, about 7 weeks after their last replacement, patient presented with worsening of gastroparesis symptoms, consistent with 2 other reported presentations of gastric electrical stimulator erosion, which penetrated the gastric mucosa.During the patient¿s hospitalization, they presented with left-sided intermittent abdominal pain for 1 week, along with erythema around the battery site with purulent drainage and associated nausea, vomiting, and diarrhea.An abdominal computed tomography scan showed gastric stimulator leads extending into the transverse colon and a small amount of fluid or soft tissue thickening around the stimulator power pack.This prompted a colonoscopy, which demonstrated 2 wires from the gastric stimulator piercing the distal transverse colon approximately 60 cm from the anus.There was also a disk-like structure attached to the distal part of the wire.After 3 days¿ treatment with daptomycin and zosyn, the implanted gastric stimulator was surgically removed, and recovered without complications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERRA
Type of Device
INTESTINAL STIMULATOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
glen belmer
7000 central avenue ne rcw215
minneapolis, MN 55432
6122713209
MDR Report Key16618888
MDR Text Key312123293
Report Number2182207-2023-00546
Device Sequence Number1
Product Code LNQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H990014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNEU_ENTERRA_INS
Device Catalogue NumberNEU_ENTERRA_INS
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/20/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient SexMale
-
-